Works by Baba, Masaru


Results: 31
    1

    Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study.

    Published in:
    Hepatology Research, 2025, v. 55, n. 3, p. 433, doi. 10.1111/hepr.14139
    By:
    • Yang, Zijian;
    • Suda, Goki;
    • Sho, Takuya;
    • Maehara, Osamu;
    • Ohara, Masatsugu;
    • Yoda, Tomoka;
    • Fu, Qingjie;
    • Sasaki, Takashi;
    • Kohya, Risako;
    • Yoshida, Sonoe;
    • Hosoda, Shunichi;
    • Kitagataya, Takashi;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Ohnishi, Shunsuke;
    • Yamamoto, Yoshiya;
    • Baba, Masaru;
    • Yamada, Ren
    Publication type:
    Article
    2

    Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 191, doi. 10.1111/hepr.14117
    By:
    • Ogawa, Yuji;
    • Tomeno, Wataru;
    • Imamura, Yasushi;
    • Baba, Masaru;
    • Ueno, Takato;
    • Kobayashi, Takashi;
    • Iwaki, Michihiro;
    • Nogami, Asako;
    • Kessoku, Takaomi;
    • Honda, Yasushi;
    • Notsumata, Kazuo;
    • Fujikawa, Hirotoshi;
    • Kaai, Megumi;
    • Imajo, Kento;
    • Kawanaka, Miwa;
    • Hyogo, Hideyuki;
    • Hisatomi, Mitsurou;
    • Takeuchi, Mamiko;
    • Hakamada, Taku;
    • Honda, Takashi
    Publication type:
    Article
    3

    Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.

    Published in:
    Hepatology Research, 2021, v. 51, n. 9, p. 979, doi. 10.1111/hepr.13693
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya
    Publication type:
    Article
    4

    Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.

    Published in:
    Hepatology Research, 2020, v. 50, n. 8, p. 966, doi. 10.1111/hepr.13511
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ito, Jun;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi;
    • Saga, Akiyoshi;
    • Miyagishima, Takuto
    Publication type:
    Article
    5

    Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 11, p. 1294, doi. 10.1111/hepr.13399
    By:
    • Suzuki, Kazuharu;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Shimazaki, Tomoe;
    • Yamamoto, Koji;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    6

    Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
    By:
    • Izumi, Takaaki;
    • Sho, Takuya;
    • Morikawa, Kenichi;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Umemura, Machiko;
    • Shimazaki, Tomoe;
    • Kimura, Megumi;
    • Nakai, Masato;
    • Suda, Goki;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Kudo, Yusuke;
    • Nishida, Mutsumi;
    • Ono, Kota;
    • Baba, Masaru;
    • Furuya, Ken
    Publication type:
    Article
    7

    Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.

    Published in:
    Cancers, 2022, v. 14, n. 16, p. 3938, doi. 10.3390/cancers14163938
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Ogawa, Koji;
    • Kubo, Akinori;
    • Tokuchi, Yoshimasa;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Kimura, Megumi;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Nakamura, Akihisa;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato
    Publication type:
    Article
    8
    9
    10
    11

    Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.

    Published in:
    JGH Open, 2020, v. 4, n. 1, p. 54, doi. 10.1002/jgh3.12209
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Shimazaki, Tomoe;
    • Maehara, Osamu;
    • Shigesawa, Taku;
    • Suzuki, Kazuharu;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Morikawa, Kenichi;
    • Furuya, Ken;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Kobayashi, Tomoe;
    • Meguro, Takashi
    Publication type:
    Article
    12

    Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56947-1
    By:
    • Ogawa, Koji;
    • Kobayashi, Takashi;
    • Furukawa, Jun-ichi;
    • Hanamatsu, Hisatoshi;
    • Nakamura, Akihisa;
    • Suzuki, Kazuharu;
    • Kawagishi, Naoki;
    • Ohara, Masatsugu;
    • Umemura, Machiko;
    • Nakai, Masato;
    • Sho, Takuya;
    • Suda, Goki;
    • Morikawa, Kenichi;
    • Baba, Masaru;
    • Furuya, Ken;
    • Terashita, Katsumi;
    • Kobayashi, Tomoe;
    • Onodera, Manabu;
    • Horimoto, Takahiro;
    • Shinada, Keisuke
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.

    Published in:
    PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247728
    By:
    • Shigesawa, Taku;
    • Suda, Goki;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Tokuchi, Yoshimasa;
    • Kubo, Akinori;
    • Yamada, Ren;
    • Furuya, Ken;
    • Baba, Masaru;
    • Kitagataya, Takashi;
    • Suzuki, Kazuharu;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    22
    23

    Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1315, doi. 10.1111/apt.18229
    By:
    • Yasuura, Naohiro;
    • Suda, Goki;
    • Ohara, Masatsugu;
    • Meno, Akimitsu;
    • Sho, Takuya;
    • Kohya, Risako;
    • Sasaki, Takashi;
    • Yoda, Tomoka;
    • Yoshida, Sonoe;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Hosoda, Shunichi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Saitou, Tomoya;
    • Sugiyama, Masaya;
    • Fukuhara, Takasuke;
    • Baba, Masaru;
    • Kitagataya, Takashi;
    • Kawagishi, Naoki
    Publication type:
    Article
    24

    Helicobacter fennelliae Localization to Diffuse Areas of Human Intestine, Japan.

    Published in:
    Emerging Infectious Diseases, 2024, v. 30, n. 1, p. 129, doi. 10.3201/eid3001.231049
    By:
    • Sakoh, Takashi;
    • Miyajima, Emiko;
    • Endo, Yusuke;
    • Kono, Kei;
    • Sato, Junichiro;
    • Haraguchi, Mizuki;
    • Ogura, Sho;
    • Morishima, Masayo;
    • Ishida, Keiko;
    • Ochiai, Yorinari;
    • Hoteya, Shu;
    • Takazawa, Yutaka;
    • Baba, Masaru;
    • Araoka, Hideki
    Publication type:
    Article
    25

    Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 1, p. 181, doi. 10.3390/v15010181
    By:
    • Kawagishi, Naoki;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Baba, Masaru;
    • Furuya, Ken;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Yoshida, Sonoe;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Hosoda, Shunichi;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Ohara, Masatsugu;
    • Suzuki, Kazuharu;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Ogawa, Koji;
    • Sakamoto, Naoya
    Publication type:
    Article
    26

    Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis.

    Published in:
    Journal of Medical Virology, 2023, v. 95, n. 2, p. 1, doi. 10.1002/jmv.28452
    By:
    • Suda, Goki;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Sho, Takuya;
    • Ogawa, Koji;
    • Kimura, Megumi;
    • Hosoda, Shunichi;
    • Yoshida, Sonoe;
    • Kubo, Akinori;
    • Fu, Qingjie;
    • Yang, Zijian;
    • Tokuchi, Yoshimasa;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Yamada, Ren;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato
    Publication type:
    Article
    27

    Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.

    Published in:
    Journal of Gastroenterology, 2021, v. 56, n. 2, p. 168, doi. 10.1007/s00535-020-01750-3
    By:
    • Suzuki, Kazuharu;
    • Suda, Goki;
    • Yamamoto, Yoshiya;
    • Furuya, Ken;
    • Baba, Masaru;
    • Nakamura, Akinobu;
    • Miyoshi, Hideaki;
    • Kimura, Megumi;
    • Maehara, Osamu;
    • Yamada, Ren;
    • Kitagataya, Takashi;
    • Yamamoto, Koji;
    • Shigesawa, Taku;
    • Nakamura, Akihisa;
    • Ohara, Masatsugu;
    • Kawagishi, Naoki;
    • Nakai, Masato;
    • Sho, Takuya;
    • Natsuizaka, Mitsuteru;
    • Morikawa, Kenichi
    Publication type:
    Article
    28
    29
    30

    Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 769, doi. 10.1007/s11523-024-01092-7
    By:
    • Sho, Takuya;
    • Suda, Goki;
    • Ohara, Masatsugu;
    • Kohya, Risako;
    • Sasaki, Takashi;
    • Yoshida, Sonoe;
    • Hosoda, Shunichi;
    • Ogawa, Koji;
    • Kitagataya, Takashi;
    • Maehara, Osamu;
    • Ohnishi, Shunsuke;
    • Kawagishi, Naoki;
    • Natsuizaka, Mitsuteru;
    • Nakai, Masato;
    • Baba, Masaru;
    • Yamamoto, Yoshiya;
    • Tsukuda, Yoko;
    • Meguro, Takashi;
    • Yamada, Ren;
    • Kobayashi, Tomoe
    Publication type:
    Article
    31